Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 859 clinical trials
Radium-223 and Radiotherapy in Hormone-Na ve Men With Oligometastatic Prostate Cancer to Bone

This is a phase IIa, open label, single arm, and prospective study of hormone therapy-nave men with oligometastatic prostate cancer to the bone. The study will test if treating the primary tumor

  • 3 views
  • 27 Jan, 2021
  • 1 location
Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

acquisition, study participants will take a 7- to 56-day (1-8 weeks) course of letrozole in accordance with standard of care. They will then undergo definitive surgical resection of their primary tumor

lumpectomy
breast carcinoma
renal function
measurable disease
letrozole
  • 6 views
  • 25 Jan, 2021
  • 1 location
Drug Sensitivity Screening for Gastrointestinal Cancer

> The study will collect primary tumor tissues from stage III/IV gastrointestinal cancer patients who underwent emergency surgeries, and then establish the primary tumor cell library for ex vivo

  • 0 views
  • 24 Jan, 2021
  • 1 location
OMEGA Local Ablative Therapy in Oligometastatic NSCLC

tumors has been designed. Inclusion criteria include adequate performance status, primary tumor controlled or controllable staging with whole-body FDG PET scan and brain MRI, fit to receive at

ct scan
lung carcinoma
EGFR
brain metastases
metastasis
  • 0 views
  • 23 Jan, 2021
  • 1 location
Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal Cancer

The immune response at primary tumor has a major role in the prognosis of colorectal cancer (CRC). Some studies suggest a prognosis value of cytotoxic T cell and memory T cells at primary tumor

  • 0 views
  • 25 Jan, 2021
  • 1 location
-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence

rectal cancer with curative intent generally includes resection of the primary tumor. Despite its crucial role, surgery by itself induce physiological changes resulting in significant immune

prevention of colorectal cancer
metastasis
rectal carcinoma
carcinoma
  • 17 views
  • 07 Nov, 2020
  • 2 locations
Induction Chemotherapy Radiochemotherapy Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer

10%, but has only had limited effect on overall survival due to the constantly high (more than 30%) rate of distant metastasis. Complete eradication of the primary tumour observed in the

adenocarcinoma of rectum
renal function
total mesorectal excision
chemoradiotherapy
adenocarcinoma
  • 1 views
  • 08 Nov, 2020
  • 1 location
Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer

After multimodal therapy of head-and-neck tumors, patients often develop local recurrence, locally progressive disease or second primary tumors. In this highly pre-treated patient cohort

  • 0 views
  • 25 Jan, 2021
  • 1 location
IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment

potentially better response to treatment. In advanced rectal adenocarcinoma excellent response to preoperative radiochemotherapy with complete eradication of the primary tumor observed in the

renal function
adenocarcinoma
adenocarcinoma of rectum
capecitabine
platelet count
  • 3 views
  • 08 Nov, 2020
  • 1 location
Preoperative CRT With Capecitabine Temozolomide in Patients With LARC

endpoint is pathologic complete response rates defined as total regression of the primary tumor. For each cohort of MGMT hypermethylated versus MGMT unmethylated, patients will be randomised (ratio

  • 13 views
  • 27 Jan, 2021
  • 1 location